This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
10
Check minimum number of events None
10
Include endpoints None
10
Remove individuals based on genotype QC
10
E4_POLYHYPER
Control definitions
Control exclude
E4_ENDOGLAND
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E31
Name in latin
Hyperfunctio polyglandularis
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Polyglandular hyperfunction
based on the number of shared cases.
Broader endpoints:
- Polyglandular dysfunction
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Factors influencing health status and contact with health services
- Any operation in hilmo
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 10 | 9 | - |
| Unadjusted prevalence (%) | 0.00 | 0.00 | - |
| Mean age at first event (years) | 41.44 | 41.30 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_POLYHYPER – Polyglandular hyperfunction
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Polyglandular hyperfunction
↥Endpoint not on priority list, no data to show.